France
# |
Name |
Goodwill |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 35.54 M
|
Dec. 31, 2023 | USD 1.45 | 1.71% |
|
France |
|
2 |
USD 27.29 M
|
Dec. 31, 2023 | USD 0.65 | 1.19% |
|
France |
|
3 |
USD 20.33 M
|
Dec. 31, 2023 | USD 5.91 | -2.66% |
|
France |
|
4 |
USD 2.47 M
|
Dec. 31, 2023 | USD 21.38 K | 0.34% |
|
France |
|
5 |
USD 1.00
|
Dec. 31, 2023 | USD 4.22 | -0.94% |
|
France |
|
6 |
USD 0.00
|
Dec. 31, 2023 | USD 3.87 | -3.39% |
|
France |
|
7 |
USD 0.00
|
Dec. 31, 2023 | USD 1.39 | 1.77% |
|
France |
|
8 |
USD 0.00
|
Dec. 31, 2023 | USD 1.64 | 4.90% |
|
France |
|
9 |
USD 0.00
|
Dec. 31, 2023 | USD 2.01 | -0.78% |
|
France |
|
10 |
USD 0.00
|
Dec. 31, 2023 | USD 2.43 | 0.68% |
|
France |
|
11 |
USD 0.00
|
Dec. 31, 2023 | USD 7.66 | 0.25% |
|
France |
|
12 |
USD 0.00
|
March 31, 2024 | USD 16.83 | 1.50% |
|
France |
|
13 |
USD 0.00
|
Dec. 31, 2023 | USD 3.47 | -1.52% |
|
France |
|
14 |
USD 0.00
|
Dec. 31, 2023 | USD 6.63 | -0.22% |
|
France |
|
15 |
USD 0.00
|
Dec. 31, 2023 | USD 2.06 | -0.75% |
|
France |
|
16 |
USD 0.00
|
Dec. 31, 2023 | USD 3.91 | 3.55% |
|
France |
|
17 |
USD 0.00
|
Dec. 31, 2023 | USD 5.64 | -2.27% |
|
France |
|
18 |
USD 0.00
|
Dec. 31, 2023 | USD 2.58 | -11.21% |
|
France |
|
19 |
USD 0.00
|
Dec. 31, 2023 | USD 2.03 | 3.98% |
|
France |
|
20 |
USD 0.00
|
Dec. 31, 2023 | USD 3.55 | 2.04% |
|
France |
The Clinical Trials company in France with the highest Goodwill is Affluent Medical SA (Paris Stock Exchange: AFME.PA) at USD 35.54 M.
The Clinical Trials company in France with the lowest Goodwill is Median Technologies SA (Paris Stock Exchange: ALMDT.PA) at USD 0.00.
The top 10 Clinical Trials companies in France by Goodwill are Affluent Medical SA, Novacyt S.A., ABIVAX SA, Eurofins-Cerep SA, DBV Technologies S.A., Predilife S.A., Valbiotis SA, AB Science S.A., Innate Pharma S.A. and Inventiva S.A..
The bottom 10 Clinical Trials companies in France by Goodwill are Median Technologies SA, Crossject SA, Aelis Farma SA, Adocia SA, Genfit S.A., Advicenne S.A., OSE Immunotherapeutics SA, Nanobiotix S.A., MedinCell S.A. and MaaT Pharma SA.